1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation
2024) In Cardiovascular Research(
- Contribution to journal › Article
- 2023
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
-
Mark
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction
(
- Contribution to journal › Article
-
Mark
Invariant natural killer T cells and incidence of first-time coronary events : a nested case-control study
(
- Contribution to journal › Article
- 2020
-
Mark
Low Levels of CD4+CD28null T Cells at Baseline Are Associated With First-Time Coronary Events in a Prospective Population-Based Case-Control Cohort
(
- Contribution to journal › Article
- 2019
-
Mark
Circulating Monocyte Chemoattractant Protein-1 and Risk of Stroke : Meta-Analysis of Population-Based Studies Involving 17 180 Individuals
(
- Contribution to journal › Article
- 2018
-
Mark
IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis
(
- Contribution to journal › Article
- 2016
-
Mark
Associations between macrophage colony-stimulating factor and monocyte chemotactic protein 1 in plasma and first-time coronary events : A Nested case-control Study
(
- Contribution to journal › Article
- 2015
-
Mark
A high quality diet is associated with reduced systemic inflammation in middle-aged individuals.
(
- Contribution to journal › Article
-
Mark
High Plasma Levels of Heparin-Binding Epidermal Growth Factor Are Associated With a More Stable Plaque Phenotype and Reduced Incidence of Coronary Events.
(
- Contribution to journal › Article